Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
ACS Omega
|
May 16, 2022
Life Cycle Assessment and Multiobjective Optimization for Steam Cracking Process in Ethylene Plant
Wenhong Shen, Zhou Tian, Liang Zhao, et al.
Annals of Hematology
|
April 13, 2021
HLA-DQB1 mismatch increase risk of severe bleeding independently in recipients of allogeneic stem cell transplant
Jiaqian Qi, Rui Zhang, Chengsen Cai, et al.
Molecular Carcinogenesis
|
November 2, 2022
Blast phase of chronic myeloid leukemia with concurrent BCR::ABL1 and SET::NUP214: A report of two cases
Yan Chen, Qian Wang, Jiannong Cen, et al.
Oncology Letters
|
August 10, 2017
Clinical significance of circulating microparticles in Ph<sup>-</sup> myeloproliferative neoplasms
Wenjuan Zhang, Jiaqian Qi, Shixiang Zhao, et al.
American Journal of Cancer Research
|
October 17, 2018
Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia
Xiaowen Tang, Lin Yang, Zheng Li, et al.
American Journal of Cancer Research
|
July 24, 2018
First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia
Xiaowen Tang, Lin Yang, Zheng Li, et al.
Experimental Hematology & Oncology
|
September 29, 2022
CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia
Xuanqi Cao, Haiping Dai, Qingya Cui, et al.
Journal of Hematology & Oncology
|
May 26, 2021
CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Qingya Cui, Chongsheng Qian, Nan Xu, et al.
Hematological Oncology
|
October 4, 2021
TNF-α increases the risk of bleeding in patients after CAR T-cell therapy: A bleeding model based on a real-world study of Chinese CAR T Working Party
Jiaqian Qi, Xin Lv, Jia Chen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
ACS Omega
|
May 16, 2022
Life Cycle Assessment and Multiobjective Optimization for Steam Cracking Process in Ethylene Plant
Wenhong Shen, Zhou Tian, Liang Zhao, et al.
Annals of Hematology
|
April 13, 2021
HLA-DQB1 mismatch increase risk of severe bleeding independently in recipients of allogeneic stem cell transplant
Jiaqian Qi, Rui Zhang, Chengsen Cai, et al.
Molecular Carcinogenesis
|
November 2, 2022
Blast phase of chronic myeloid leukemia with concurrent BCR::ABL1 and SET::NUP214: A report of two cases
Yan Chen, Qian Wang, Jiannong Cen, et al.
Oncology Letters
|
August 10, 2017
Clinical significance of circulating microparticles in Ph<sup>-</sup> myeloproliferative neoplasms
Wenjuan Zhang, Jiaqian Qi, Shixiang Zhao, et al.
American Journal of Cancer Research
|
October 17, 2018
Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia
Xiaowen Tang, Lin Yang, Zheng Li, et al.
American Journal of Cancer Research
|
July 24, 2018
First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia
Xiaowen Tang, Lin Yang, Zheng Li, et al.
Experimental Hematology & Oncology
|
September 29, 2022
CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia
Xuanqi Cao, Haiping Dai, Qingya Cui, et al.
Journal of Hematology & Oncology
|
May 26, 2021
CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Qingya Cui, Chongsheng Qian, Nan Xu, et al.
Hematological Oncology
|
October 4, 2021
TNF-α increases the risk of bleeding in patients after CAR T-cell therapy: A bleeding model based on a real-world study of Chinese CAR T Working Party
Jiaqian Qi, Xin Lv, Jia Chen, et al.
Page
of 1